Molecular mechanism underlying the functional loss of cyclindependent kinase inhibitors p16 and p27 in hepatocellular carcinoma

Matsuda, Yasunobu; Seng-Lai Tan
March 2008
World Journal of Gastroenterology;3/21/2008, Vol. 14 Issue 11, p1734
Academic Journal
Hepatocellular carcinoma (HCC) is one of the most common human cancers, and its incidence is still increasing in many countries. The prognosis of HCC patients remains poor, and identification of useful molecular prognostic markers is required. Many recent studies have shown that functional alterations of cell-cycle regulators can be observed in HCC. Among the various types of cell-cycle regulators, p16 and p27 are frequently inactivated in HCC and are considered to be potent tumor suppressors. p16, a G1-specific cell-cycle inhibitor that prevents the association of cyclindependent kinase (CDK) 4 and CDK6 with cyclin D1, is frequently inactivated in HCC via CpG methylation of its promoter region. p16 may be involved in the early steps of hepatocarcinogenesis, since p16 gene methylation has been detected in subsets of pre-neoplastic liver cirrhosis patients. p27, a negative regulator of the G1-S phase transition through inhibition of the kinase activities of Cdk2/cyclin A and Cdk2/cyclin E complexes, is now considered to be an adverse prognostic factor in HCC. In some cases of HCC with increased cell proliferation, p27 is overexpressed but inactivated by sequestration into cyclin D1-CDK4-containing complexes. Since loss of p16 is closely related to functional inactivation of p27 in HCC, investigating both p16 and p27 may be useful for precise prognostic predictions in individuals with HCC.


Related Articles

  • p16 and p27 are functionally correlated during the progress of hepatocarcinogenesis. Matsuda, Yasunobu; Ichida, Takafumi // Medical Molecular Morphology;Dec2006, Vol. 39 Issue 4, p169 

    The molecular mechanism of the cell-cycle machinery in hepatocellular carcinoma (HCC) has not yet been fully elucidated. Among the various types of cell-cycle regulators, p16 and p27 are now considered to be potent tumor suppressors. p16 is a G1-specific cell-cycle inhibitor that prevents the...

  • Clinical significance of cell cycle inhibitors in hepatocellular carcinoma. Matsuda, Yasunobu; Wakai, Toshifumi; Kubota, Masayuki; Takamura, Masaaki; Yamagiwa, Satoshi; Aoyagi, Yutaka; Osawa, Mami; Fujimaki, Shun; Sanpei, Ayumi; Genda, Takuya; Ichida, Takafumi // Medical Molecular Morphology;Dec2013, Vol. 46 Issue 4, p185 

    It is well accepted that cell cycle regulators are strongly implicated in the progression of cancer development. p16 and p27 are potent cyclin-dependent kinase (CDK) inhibitors involved in G1 phase progression, and are regarded as adverse prognostic biomarkers for various types of cancers. It...

  • Phospho-regulation of KIBRA by CDK1 and CDC14 phosphatase controls cell-cycle progression. JI, Ming; YANG, Shuping; CHEN, Yuanhong; XIAO, Ling; ZHANG, Lin; DONG, Jixin // Biochemical Journal;10/ 1/2012, Vol. 447 Issue 1, p93 

    KIBRA (kidney- and brain-expressed protein) is a novel regulator of the Hippo pathway, which controls tissue growth and tumorigenesis by regulating both cell proliferation and apoptosis. In mammals, KIBRA is associated with memory performance. The physiological function and regulation of KIBRA...

  • Retinoblastoma protein goes green: the role of RBR in Arabidopsis meiosis. Kurzbauer, Marie-Therese; Schlögelhofer, Peter // EMBO Journal;2/16/2011, Vol. 30 Issue 4, p631 

    No abstract available.

  • Novel direct and indirect cyclin-dependent kinase modulators for the prevention and treatment of human neoplasms. Senderowicz, Adrian M. // Cancer Chemotherapy & Pharmacology. Supplement;Jul2003, Vol. 52, p61 

    Abnormalities in the cell cycle are responsible for the majority of human neoplasias. Most abnormalities occur due to hyperphosphorylation of the tumor suppressor gene Rb by the key regulators of the cell cycle, the cyclin-dependent kinases (CDKs). Thus, a pharmacological CDK inhibitor may be...

  • Skp2 inversely correlates with p27 and tuberin in transformed cells. M. Rosner; M. Hanneder; N. Siegel; A. Valli; C. Fuchs; M. Hengstschläger // Amino Acids;Jul2009, Vol. 37 Issue 2, p257 

    Abstract  The cyclin-dependent kinase inhibitor p27Kip1 (p27) is a major gatekeeper of the mammalian cell cycle progression known to be regulated by both, its subcellular localization and its degradation. To allow entrance into S phase and thereby mammalian cell cycle progression...

  • The prognostic of p27(kip1) in ovarian cancer: a meta-analysis. Lu, Mudan; Wang, You; Xu, Fei; Xiang, Jingying; Chen, Daozhen // Archives of Gynecology & Obstetrics;Jan2016, Vol. 293 Issue 1, p169 

    Purpose: P27(kip1) is a negative cell cycle regulator that plays an important role in tumor suppression. Deregulation of p27(kip1) is commonly observed in many human cancers. Numerous studies about p27(kip1) are reported in clinical patients despite variable data for the prognostic...

  • Small interfering RNA targeting CDC25B inhibits liver tumor growth in vitro and in vivo. Xinrui Yan; Mei-Sze Chua; Jing He; So, Samuel K. // Molecular Cancer;2008, Vol. 7, Special section p1 

    Background: Using gene expression profiling, we previously identified CDC25B to be significantly highly expressed in hepatocellular carcinoma (HCC) compared to non-tumor liver. CDC25B is a cell cycle-activating phosphatase that positively regulates the activity of cyclin-dependent kinases, and...

  • Millepachine, a novel chalcone, induces G2/M arrest by inhibiting CDK1 activity and causing apoptosis via ROS-mitochondrial apoptotic pathway in human hepatocarcinoma cells in vitro and in vivo. Wu, Wenshuang; Ye, Haoyu; Wan, Li; Han, Xiaolei; Wang, Guangcheng; Hu, Jia; Tang, Minhai; Duan, Xingmei; Fan, Yi; He, Shichao; Huang, Li; Pei, Heying; Wang, Xuewei; Li, Xiuxia; Xie, Caifeng; Zhang, Ronghong; Yuan, Zhu; Mao, Yongqiu; Wei, Yuquan; Chen, Lijuan // Carcinogenesis;Jul2013, Vol. 34 Issue 7, p1636 

    In this study, we reported millepachine (MIL), a novel chalcone compound for the first time isolated from Millettia pachycarpa Benth (Leguminosae), induced cell cycle arrest and apoptosis in human hepatocarcinoma cells in vitro and in vivo. In in vitro screening experiments, MIL showed strong...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics